Chemotherapy 2019 Global Market Outlook,Research,Trends and Forecast to 2023

Apr 2, 2019

WiseGuyReports.Com Publish a New Market Research Report On –“ Chemotherapy 2019 Global Market Outlook,Research,Trends and Forecast to 2023”.

Pune, India - April 2, 2019 /MarketersMedia/ —

Chemotherapy Industry 2019

Description:-

This report analyzes the chemotherapy market by drugs (alkylating agents, antimetabolites), by route of drug administration (oral, intravenous), by indication (leukemia, lymphoma, breast cancer), end-user (hospitals, research institute); it also studies the top manufacturers in the market.

The chemotherapy market is projected to grow at a CAGR of near about 6.2% during the forecast period 2017-2023.

The major players in chemotherapy market include:
• Sanofi (France)
• Novartis (Germany)
• Pfizer Inc. (U.S.)
• Eli Lilly & Company (U.S.)
• ImClone Systems Inc. (U.S.)
• GlaxoSmithKline (U.K.)
• AstraZeneca (U.K)
• Schering-Plough (U.S.)
• Boehringer Ingelheim (Germany)
• Bristol-Myers Squibb
• Teva Pharmaceuticals Industries (Japan)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Merck & Co., Inc. (U.S.)
• Chemo Espana SL (Spain)
• CELGENE CORPORATION (U.S.)
• Amgen Inc (U.S.)
• Bayer AG (Germany)
• Takeda Pharmaceutical Company Limited (Japan)
• Others

Get a Free Sample Report @ https://www.wiseguyreports.com/sample-request/3496566-chemotherapy-market-research-report-forecast-to-2023

For more information or any query mail at [email protected]

The market revenue and share have been analyzed with respect to the following regions and countries:
Americas
North America
U.S.
Canada
South America
Europe
Western Europe
U.K.
France
Germany
Italy
Spain
Rest of Western Europe
Eastern Europe
Asia-Pacific
China
Japan
India
Australia
Republic of Korea
Rest of Asia-Pacific
Middle East & Africa
United Arab Emirates
Saudi Arabia
Oman
Kuwait
Qatar
Rest of The Middle East & Africa

On the basis of drugs, the chemotherapy market has been categorized into the following segments:

• Alkylating Agents
• Antimetabolites

On the basis of route of drug administration, the chemotherapy market has been categorized into the following segments:
• Oral
• Intravenous

On the basis of indication, the chemotherapy market has been categorized into the following segments:
• Leukemia
• Lymphoma
• Breast Cancer

On the basis of end-user, the chemotherapy market has been categorized into the following segments:
• Hospitals
• Research Institute

……...

Enquiry About Report @ https://www.wiseguyreports.com/enquiry/3496566-chemotherapy-market-research-report-forecast-to-2023

Table Of Contents – Major Key Points

1. Report Prologue

2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations

3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation

4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment

5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis

6. Global Chemotherapy Market, By Drug
6.1 Introduction
6.2 Alkylating Agents
6.2.1 Market Estimates & Forecast, 2017–2023
6.3 Antimetabolites
6.3.1 Market Estimates & Forecast, 2017–2023
6.4 Anti-Tumor Antibiotics
6.4.1 Market Estimates & Forecast, 2017–2023
6.5 Topoisomerase Inhibitors
6.5.1 Market Estimates & Forecast, 2017–2023
6.6 Mitotic Inhibitors
6.6.1 Market Estimates & Forecast, 2017–2023

Continued……

Buy 1-user PDF @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3496566

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Contact Info:
Name: Norah Trent
Email: Send Email
Organization: WiseGuy Research Consultant Pvt Ltd.
Address: Office No.528,Amanora Chambers,Magarpatta Road,Hadapsar,Pune-411028.
Phone: +1-646-845-9349
Website: https://www.wiseguyreports.com

Source URL: https://marketersmedia.com/chemotherapy-2019-global-market-outlookresearchtrends-and-forecast-to-2023/497761

Source: MarketersMedia

Release ID: 497761

More News

Google Korea finally wins tax dispute against Korean tax office

Oct 12, 2026

Google Korea finally wins tax dispute against Korean tax office

The Supreme Court has dismissed an appeal by Korea's tax authority, effectively upholding a lower court's ruling in favor of Google Korea in a corporate tax cancellation case involving about 154 billion won ($115.3 million), judicial officials said Monday. The top court left intact the Seoul High Court's ruling siding with Google Korea in its corporate tax cancellation lawsuit against the head of Seoul's Yeoksam Tax Office by dismissing the defendant's appeal without substantive review Thursday, the officials said. The tax office imposed corporate and local income taxes totaling around 154 billion won on Google Korea in 2020, arguing that the company's transfer of part of its income to Google Asia Pacific based in Singapore was subject to taxation. The office classified the payments as royalty income derived from the use of copyrights and knowhow. But Google Korea took the case to court, arguing that the payments constituted business income for Google Asia Pacific and were therefore not taxable in Korea. The Seoul Administrative Court ruled in favor of Google Korea, finding that the paym

Celltrion Q3 operating profit tops W500 bil. mark for 1st time

Oct 12, 2026

Celltrion Q3 operating profit tops W500 bil. mark for 1st time

Biotech company Celltrion said Monday that its operating profit for the third quarter of 2026 is expected to surpass the 500 billion won ($374.3 million) mark for the first time, driven by robust sales in global markets. In its earnings guidance released Monday, the company forecast 1.5 trillion won in sales and 510 billion won in operating profit for the three-month period, representing year-on-year increases of 45.8 percent and 69.2 percent, respectively. Both sales and operating profit reached record quarterly highs, with operating profit surpassing 500 billion won for the first time since the company's establishment. Celltrion said its profitability has improved due to a growing share of high-margin products in its sales mix and improvements in its cost structure. Earlier this year, Celltrion set quarterly operating profit targets of more than 300 billion won for the first quarter, 400 billion won for the second and 500 billion won for the third. The company said it has exceeded its targets in each of the first three quarters, demonstrating that its profit growth has progressed as p

Less paperwork, AI-powered banking: KakaoBank joins race for foreign customers

Oct 12, 2026

Less paperwork, AI-powered banking: KakaoBank joins race for foreign customers

KakaoBank on Monday launched a range of financial services for international residents in Korea, joining local lenders in the race to attract customers from the country's growing foreign population. The new offering from the internet-only lender includes checking accounts, debit cards, overseas remittances and artificial intelligence (AI)-powered multilingual support. "Even though banking has become much more convenient for domestic customers, foreign residents still face the kind of inconvenience we experienced in the past, when we had to visit bank branches just to open an account," Bae Jung-ho, head of KakaoBank's Foreign Customer Camp, said during a press conference in Seoul. "By providing foreign residents with the same app that our 28 million customers already use, we were able to launch more than 50 services at once," he added. KakaoBank's Foreign Resident Account is available to residents aged 19 or older who have an accepted form of identification and a mobile phone registered in their name. Applicants can open an account through a mobile chatbot in about five minutes, the bank

Civic group files complaint against Kakao over alleged privacy law violations

Oct 12, 2026

Civic group files complaint against Kakao over alleged privacy law violations

A civic group filed a complaint against Kakao with the privacy watchdog on Monday, alleging that the tech giant's corporate advertising service uses personal data to target users without their consent. The Seoul YMCA said it urged the Personal Information Protection Commission (PIPC) to investigate KakaoTalk’s Brand Message service and impose strict sanctions if violations are confirmed. The group said Kakao replaced its previous channel-based advertising service, which limited promotional messages to users who had added a business’s KakaoTalk channel, with Brand Message, which allows businesses to send ads without requiring users to follow their channels. It alleged that Kakao matches phone numbers provided by advertisers with its own user database to identify ad recipients, even though users had provided their numbers for basic messaging functions, not to receive third-party advertising. “The key alleged violations involve the unauthorized use of personal information and infringement of users’ rights,” the group said. “Although users agreed to provide their phone numbers for

AI pioneer sees Korea's role in developing world model

Oct 12, 2026

AI pioneer sees Korea's role in developing world model

Developing industrial artificial intelligence (AI) requires "world AI" capable of understanding the physical world, and Korea has an increasingly important role to play in this field, according to Yann LeCun, widely regarded as one of the four leading figures in the global AI academia. LeCun and a number of other leading experts shared their views during the Global AI Leaders Seoul Dialogue, an event organized ahead of the fifth International Industrial AI Conference, scheduled for Tuesday in Tokyo. LeCun is a leading AI scientist, a recipient of the 2018 Turing Award, founder of AMI Labs and former chief AI scientist and vice president at Meta. He is known for pioneering convolutional neural networks, which revolutionized image recognition. He also serves as chief science adviser to Project Tapestry, an AI Alliance-led initiative to develop a large-scale AI model through federated learning, which allows AI models to learn from data stored across different countries or companies without requiring the data to be transferred to a central server. Christopher Nguyen, CEO of Aitomatic and chi

Air Premia captures 20% market share on LA route in 4th year of service

Oct 12, 2026

Air Premia captures 20% market share on LA route in 4th year of service

Korean budget airline Air Premia has captured more than 20 percent of passenger traffic carried by domestic carriers on the Incheon–Los Angeles route, marking four years of service on its flagship transpacific corridor. The airline said Monday that it transported 759,277 passengers on the route from its launch on Oct. 29, 2022, through September, recording an average share of 15.8 percent among Korean carriers over the period. Its share rose steadily from 12.9 percent in its first year to 14 percent in its second and 15.3 percent in its third, before reaching 20.8 percent in its fourth year. International demand has also grown, with passengers holding foreign nationalities accounting for 44.8 percent of total travelers over the four-year period. Their share climbed from 40.2 percent in the first year to 41.1 percent in the second and 47.2 percent in the third, reaching 49.6 percent in the fourth year. To mark the anniversary, Air Premia is offering promotional fares across five U.S. routes: Los Angeles, New York, San Francisco, Washington, D.C., and Honolulu. Round-trip fares on the Los

Hyosung Chemical brings high-performance plastics to Europe for EVs, robots

Oct 12, 2026

Hyosung Chemical brings high-performance plastics to Europe for EVs, robots

Hyosung Chemical, a major Korean producer of advanced industrial polymers, is pushing its high-performance plastics into the European market. The company is targeting automakers and robotics manufacturers with specialized materials engineered for exceptional chemical resistance and durability under friction. The Korean chemical maker is participating in Fakuma 2026, an international plastics processing trade fair running from Monday through Oct. 16 in Friedrichshafen, Germany, where it is presenting its POKETONE material and applications across several industries. POKETONE is engineered to resist impact, abrasion and chemical exposure while absorbing little moisture, helping components maintain their shape and dimensions, the company said. Its strength, wear resistance and flame-retardant properties can also be tailored to specific applications, making it suitable for a range of industrial uses. Hyosung Chemical is highlighting automotive connectors, gears, drive components and medical parts under the exhibition theme “Automotive, Robotics, Medical.” The material is also finding poten

HLB resubmits FDA application for liver cancer treatment

Oct 12, 2026

HLB resubmits FDA application for liver cancer treatment

Korean drugmaker HLB has resubmitted its application for U.S. approval of a combination therapy for advanced liver cancer, renewing its push to bring the target treatment to market after addressing regulatory concerns raised earlier this year. The Korean biopharmaceutical company said Monday that its U.S. subsidiary, Elevar Therapeutics, and Chinese partner Hengrui Pharma submitted the application to the U.S. Food and Drug Administration (FDA) on Friday, seeking approval of rivoceranib in combination with camrelizumab as a first-line treatment for liver cancer. The resubmission follows an FDA complete response letter issued in July regarding an application Elevar filed in January, prompting the companies to work with regulators to address the agency’s concerns. HLB said inspections of the manufacturing facilities have recently been completed, allowing the companies to submit the application again. The filing is based on CARES-310, a global Phase 3 clinical trial involving patients with unresectable or metastatic liver cancer. In the trial’s final analysis, the combination treatment ac

Claude emerges as fastest-growing AI skill in Korean job postings

Oct 12, 2026

Claude emerges as fastest-growing AI skill in Korean job postings

Korean employers are no longer just asking job candidates if they understand artificial intelligence (AI). Instead, they are requiring hands-on expertise with specific platforms — and Claude is leading the surge in recruitment demand. According to data released Monday by JobKorea, a human resources technology platform operated by Worksphere, recruitment postings mentioning generative AI tools like Claude, ChatGPT and Gemini jumped 170 percent in the third quarter compared to the same period last year. Among individual tools, Claude recorded the sharpest increase, with mentions climbing 770 percent, followed by Google’s Gemini at 500 percent, ChatGPT at 165 percent, Microsoft Copilot at 96 percent and Midjourney at 46 percent. Claude’s share of postings that named specific AI tools jumped from 17 percent last year to 55 percent this year, narrowing the gap with ChatGPT, whose share remained around 70 percent over the same period, according to JobKorea. Demand also grew for skills related to how AI is applied, with mentions of generative AI, prompt engineering, AI agents and vibe cod

Naver Map to offer voice guidance on Meta, Google, Samsung smart glasses

Oct 12, 2026

Naver Map to offer voice guidance on Meta, Google, Samsung smart glasses

Naver Map, Korea’s most widely used online map service, will offer real-time, step-by-step voice navigation through artificial intelligence (AI)-powered smart glasses, becoming the first Korean map service to do so, its operator, Naver, said Monday. The feature is available first on Meta’s Ray-Ban Meta and Oakley Meta glasses, according to the internet portal operator. It will also support “intelligent eyewear” being jointly developed by Google and Samsung Electronics, which is set for release later this year. Users can receive voice directions to their destination without repeatedly checking their smartphone screens. The glasses also tell them which way to turn and whether stairs or escalators lie ahead. The service will first be available on Android phones, with iPhone support to follow. Naver Map has also introduced voice commands designed for the glasses. Users can ask questions such as “When will I arrive?” or “Find a convenience store nearby” while walking and get answers right away. On the Google-Samsung glasses, users will also be able to launch Naver Map and star

Gaon Cable to make nuclear power plant cables in US

Oct 12, 2026

Gaon Cable to make nuclear power plant cables in US

Gaon Cable, an affiliate of LS Group, will build production lines for nuclear power plant cables at its U.S. plant in North Carolina, aiming to get ahead in a market expected to grow as the country expands nuclear power, the company said Monday. The Korean cable maker said its U.S. unit, LS Cable & System U.S.A., will install the equipment at its plant in Tarboro, North Carolina. The move is intended to build a local supply system ahead of the expected expansion of the U.S. market for large nuclear plants and small modular reactors (SMRs), smaller reactors that can be factory-built and installed in modules. The plant already produces overhead power lines for the U.S. grid. Adding nuclear cables will widen the range of products it makes locally. The company said the U.S. supply chain for nuclear plant equipment, including cables, remains thin because few new reactors have been built in the country for decades. Interest in new reactors has returned as electricity demand rises with the growing number of artificial intelligence data centers and as energy security becomes a priority. A single

SK Group opens 2-year AI academy with $2,200 monthly allowance

Oct 12, 2026

SK Group opens 2-year AI academy with $2,200 monthly allowance

SK Group will launch a two-year, full-time, non-degree program for aspiring developers and early-career innovators focused on using artificial intelligence (AI) to solve real-world problems, the conglomerate said Monday. Participants in the initiative will receive a monthly stipend of 3 million won (approximately $2,200) to support their intensive training and practical application projects. The program, SK AIGEN, combines “AI” and “generation.” It is open to people aged 19 to 34 and will start in March 2027 with about 50 participants. Participants will receive the monthly stipend for two years, along with training, mentoring and workspace. The program does not guarantee a job at SK or grant a degree, and participants have no obligations after completing it. In the first year, participants will plan and carry out individual or team projects that use AI to tackle problems faced by individuals, companies and society. In the second year, they will gain hands-on experience in fields tied to their own career or project plans, with SK connecting them to mentors and experts. SK said this

Recommended

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Scienfinite

Scienfinite publishes articles with a unique approach to inspire our readers with the aim to understand the world and appreciate its everyday awe.

Terms
Privacy Policy
Press
Advertisement
Contact

Copyright © 2015 - 2026 Scienfinite. All Rights Reserved.